The main objective of this review is to examine the pharmacokinetics of five peptide-derived incretin mimetic medicationsexenatide, liraglutide, dulaglutide, semaglutide, and tirzepatideincluding GLP-1 RAs and a dual GLP-1/GIP RA currently used in the market
Luckily, these discomforts often subside after the first few weeks
But before jumping on the bandwagon and trying this medication, it is important to understand what exactly Semaglutide is and how it works
It sets requirements for ingredient sourcing, equipment calibration, and beyond-use dating (the expiration date assigned to the compounded product) [7]
After starting the initial 0.25 mg dose in the first week, most patients will experience some mild gastrointestinal side effects, such as nausea or abdominal discomfort, as their body adjusts to the medication
The semaglutide mixing chart provides reconstitution guidance for common vial sizes, while the 10 mg mixing chart covers higher concentration preparations